Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Park Nicollet Institute International Diabetes Center Eli Lilly and Company Novo Nordisk United Health Care Merck |
---|---|
Information provided by: | Park Nicollet Institute |
ClinicalTrials.gov Identifier: | NCT00824603 |
The purpose of this study is to determine if a continuing medical education (CME) program can change primary care providers' use of insulin therapy - their confidence in selecting doses and engagement of patients in the decision making as to whether to initiate insulin therapy.
Condition |
---|
Diabetes |
Study Type: | Observational |
Study Design: | Cohort, Cross-Sectional |
Official Title: | Impact of CME Program on Self-Reported Confidence and Use of Insulin in Persons With Type 2 Diabetes |
Estimated Enrollment: | 300 |
Study Start Date: | June 2006 |
Estimated Study Completion Date: | June 2010 |
Groups/Cohorts |
---|
primary care provider
attending insulin CME Training
|
We will determine whether attendees' self-reported confidence and use of insulin with persons with type 2 diabetes changes after they attend the CME program. Specifically, we will address the following questions:
Question 1. Clinical guidelines. Is insulin initiated earlier (at a lower A1C)?
Question 2. Decision-making. Does confidence in selecting a starting insulin regimen change? Does confidence in selecting a starting insulin dose change? Does confidence in adjusting insulin change? Does confidence in discussion nutrition guidelines change?
Question 3. Application. Do more patients start using insulin? Who usually selects starting dose? How is starting dose selected? How often is insulin adjusted?
Question 4. Resources. How available are protocols for insulin use? How available is adequate time to monitor insulin therapy? How available is staff to teach insulin injections? How available is staff to help adjust insulin?
Ages Eligible for Study: | 25 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Primary care providers affiliated with the participating healthcare organizations were invited to attend.
Inclusion Criteria:
Exclusion Criteria:
-
United States, Minnesota | |
International Diabetes Center | |
Minneapolis, Minnesota, United States, 55416 |
Principal Investigator: | Margaret Powers, PhD | International Diabetes Center |
Responsible Party: | International Diabetes Center ( Margaret Powers, PhD ) |
Study ID Numbers: | 03425-06-C |
Study First Received: | January 15, 2009 |
Last Updated: | January 16, 2009 |
ClinicalTrials.gov Identifier: | NCT00824603 History of Changes |
Health Authority: | United States: Institutional Review Board |
Diabetes Mellitus, Type 2 Diabetes Mellitus Insulin |